Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States

Kevin Y. Xu; Carrie M. Mintz; Jacob T. Borodovsky; Paul E.A. Glaser; Laura J. Bierut; Richard A. Grucza

doi:10.4088/PCC.21br02930

Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States

Kevin Y. Xu, Carrie M. Mintz, Jacob T. Borodovsky, Paul E.A. Glaser, Laura J. Bierut, Richard A. Grucza

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	21br02930
Journal	The primary care companion for CNS disorders
Volume	23
Issue number	4
DOIs	https://doi.org/10.4088/PCC.21br02930
State	Published - 2021

Access to Document

10.4088/PCC.21br02930

Cite this

@article{397c5ab463514cdb9fa25c8f0140b4e9,

title = "Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States",

author = "Xu, {Kevin Y.} and Mintz, {Carrie M.} and Borodovsky, {Jacob T.} and Glaser, {Paul E.A.} and Bierut, {Laura J.} and Grucza, {Richard A.}",

note = "Funding Information: Published online: August 5, 2021. Potential conflicts of interest: Dr Bierut is listed as an inventor on US Patent 8080371 “Markers for Addiction,” covering use of SNPs in determining the diagnosis, prognosis, and treatment of addiction. Dr Borodovsky serves on the board of directors and is treasurer of the nonprofit MySafeRx Inc but does not receive any financial compensation for this work. Drs Xu, Mintz, Glaser, and Grucza declare no financial interests. None of the authors have financial relationships with organizations that may have an interest in this work. Funding/support: This work was supported by National Institutes of Health (NIH R25 MH112473-01, Dr Xu; R21 DA044744, Dr Grucza; U10 AA008401, R01 DA036583, Dr Bierut; K12 DA041449, Dr Mintz; R21 AA02568901 and F32 AA027941, Dr Borodovsky). Role of the sponsor: The funding sources had no role in the study design, implementation, or interpretation of results. Acknowledgments: The authors acknowledge the support of Nuri B. Farber, MD, and the Psychiatry Residency Research Education Program (PRREP) of Washington University (R25 MH112473-01) as well as the National Center for Advancing Translational Sciences of the National Institutes of Health under UL1 TR002345. Dr Farber has no conflicts of interest related to the subject of this report.",

year = "2021",

doi = "10.4088/PCC.21br02930",

language = "English",

volume = "23",

journal = "The primary care companion for CNS disorders",

issn = "2155-7772",

number = "4",

}

TY - JOUR

T1 - Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States

AU - Xu, Kevin Y.

AU - Mintz, Carrie M.

AU - Borodovsky, Jacob T.

AU - Glaser, Paul E.A.

AU - Bierut, Laura J.

AU - Grucza, Richard A.

N1 - Funding Information: Published online: August 5, 2021. Potential conflicts of interest: Dr Bierut is listed as an inventor on US Patent 8080371 “Markers for Addiction,” covering use of SNPs in determining the diagnosis, prognosis, and treatment of addiction. Dr Borodovsky serves on the board of directors and is treasurer of the nonprofit MySafeRx Inc but does not receive any financial compensation for this work. Drs Xu, Mintz, Glaser, and Grucza declare no financial interests. None of the authors have financial relationships with organizations that may have an interest in this work. Funding/support: This work was supported by National Institutes of Health (NIH R25 MH112473-01, Dr Xu; R21 DA044744, Dr Grucza; U10 AA008401, R01 DA036583, Dr Bierut; K12 DA041449, Dr Mintz; R21 AA02568901 and F32 AA027941, Dr Borodovsky). Role of the sponsor: The funding sources had no role in the study design, implementation, or interpretation of results. Acknowledgments: The authors acknowledge the support of Nuri B. Farber, MD, and the Psychiatry Residency Research Education Program (PRREP) of Washington University (R25 MH112473-01) as well as the National Center for Advancing Translational Sciences of the National Institutes of Health under UL1 TR002345. Dr Farber has no conflicts of interest related to the subject of this report.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85113678687&partnerID=8YFLogxK

U2 - 10.4088/PCC.21br02930

DO - 10.4088/PCC.21br02930

M3 - Article

C2 - 34352941

AN - SCOPUS:85113678687

SN - 2155-7772

VL - 23

JO - The primary care companion for CNS disorders

JF - The primary care companion for CNS disorders

IS - 4

M1 - 21br02930

ER -

Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States

Access to Document

Other files and links

Cite this